Literature DB >> 15451021

Mutations in the carboxy-terminus of the third intracellular loop of the human recombinant VPAC1 receptor impair VIP-stimulated [Ca2+]i increase but not adenylate cyclase stimulation.

Ingrid Langer1, Patrick Robberecht.   

Abstract

The vasoactive intestinal polypeptide (VIP) VPAC1 receptor is preferentially coupled to Galphas protein that stimulates adenylate cyclase activity and also to Galphaq and Galphai proteins that stimulate the inositol phosphate/calcium pathway. Previous studies indicated the importance of the third intracellular loop of the receptor for G protein coupling. By site-directed mutation of the human recombinant receptor expressed in Chinese hamster ovary cells, we identified two domains in this loop that contain clusters of basic residues conserved in most of the G-protein-coupled seven transmembrane domains receptors. We found that mutations in the proximal domain (K322) reduced the capability of VIP to increase adenylate cyclase activity without any change in the calcium response, whereas mutations in the distal part of the loop (R338, L339, R341) markedly reduced the calcium increase and Galphai coupling but only weakly the adenylate cyclase activity. Thus, the interaction of different G proteins with the VPAC1 receptor involves different receptor sub-domains. Copyright 2004 Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15451021     DOI: 10.1016/j.cellsig.2004.05.009

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  10 in total

1.  Pituitary adenylate cyclase-activating polypeptide induces postsynaptically expressed potentiation in the intra-amygdala circuit.

Authors:  Jun-Hyeong Cho; Ko Zushida; Gleb P Shumyatsky; William A Carlezon; Edward G Meloni; Vadim Y Bolshakov
Journal:  J Neurosci       Date:  2012-10-10       Impact factor: 6.167

Review 2.  Conformational switches in the VPAC(1) receptor.

Authors:  Ingrid Langer
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 3.  VIP-induced neuroprotection of the developing brain.

Authors:  Sandrine Passemard; Paulina Sokolowska; Leslie Schwendimann; Pierre Gressens
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

4.  VIP and VIP gene silencing modulation of differentiation marker N-cadherin and cell shape of corneal endothelium in human corneas ex vivo.

Authors:  Shay-Whey M Koh; Krish Chandrasekara; Cara J Abbondandolo; Timothy J Coll; Allan R Rutzen
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04-25       Impact factor: 4.799

5.  Similarity between class A and class B G-protein-coupled receptors exemplified through calcitonin gene-related peptide receptor modelling and mutagenesis studies.

Authors:  Shabana Vohra; Bruck Taddese; Alex C Conner; David R Poyner; Debbie L Hay; James Barwell; Philip J Reeves; Graham J G Upton; Christopher A Reynolds
Journal:  J R Soc Interface       Date:  2012-12-12       Impact factor: 4.118

6.  Development by Genetic Immunization of Monovalent Antibodies Against Human Vasoactive Intestinal Peptide Receptor 1 (VPAC1), New Innovative, and Versatile Tools to Study VPAC1 Receptor Function.

Authors:  Xavier Peyrassol; Toon Laeremans; Vannessa Lahura; Maja Debulpaep; Hassan El Hassan; Jan Steyaert; Marc Parmentier; Ingrid Langer
Journal:  Front Endocrinol (Lausanne)       Date:  2018-04-05       Impact factor: 5.555

7.  Drug Repositioning For Allosteric Modulation of VIP and PACAP Receptors.

Authors:  Ingrid Langer; Dorota Latek
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-18       Impact factor: 5.555

8.  Mechanisms involved in VPAC receptors activation and regulation: lessons from pharmacological and mutagenesis studies.

Authors:  Ingrid Langer
Journal:  Front Endocrinol (Lausanne)       Date:  2012-10-30       Impact factor: 5.555

9.  Agnathan VIP, PACAP and their receptors: ancestral origins of today's highly diversified forms.

Authors:  Stephanie Y L Ng; Billy K C Chow; Jun Kasamatsu; Masanori Kasahara; Leo T O Lee
Journal:  PLoS One       Date:  2012-09-05       Impact factor: 3.240

10.  Key interactions by conserved polar amino acids located at the transmembrane helical boundaries in Class B GPCRs modulate activation, effector specificity and biased signalling in the glucagon-like peptide-1 receptor.

Authors:  Denise Wootten; Christopher A Reynolds; Kevin J Smith; Juan C Mobarec; Sebastian G B Furness; Laurence J Miller; Arthur Christopoulos; Patrick M Sexton
Journal:  Biochem Pharmacol       Date:  2016-08-26       Impact factor: 5.858

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.